Blood-based biomarker tests the new frontier for Alzheimer’s diagnosis

In the US, the FDA is yet to grant full approval to blood-based Alzheimer’s tests, but breakthrough devices are showing high diagnostic accuracy
The post Blood-based biomarker tests the new frontier for Alzheimer’s diagnosis appeared first on Express Healthcare.